LINNEUTRAL

LIN P/E Ratio Analysis

33.5x

Updated 33h ago·SEC filings & market data

Key Takeaway

The P/E ratio of 33.5x means investors pay $33.50 for every $1 of the company's annual earnings.

Sector Performance

73th percentile

LIN

33.5x

Sector Median

23.1x

Sector Avg

33.7x

Prior Period

34.4x(Jul 2026)

↑ Improving
📊

Deep Analysis

The P/E ratio of 33.5x means investors pay $33.50 for every $1 of the company's annual earnings.

This is higher than the sector median of 23.4x, placing LIN in the 72nd percentile among its peers, so it trades at a premium valuation relative to the group. The year-over-year change is not available, but the quarter-over-quarter change is -2.7%, with the ratio easing from 34.4x to 33.5x. The combination of an above-median P/E with a slight recent decline suggests the stock carries a higher valuation risk than peers, though the downward move offers a modest margin of improvement. This metric supports the overall NEUTRAL verdict: the elevated level is a caution, but the small contraction in the multiple prevents a strongly negative read.

Frequently Asked Questions

What does the P/E Ratio tell investors about LIN?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are LIN's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: WELL (102.4x), IAC (104.9x), FORM (108.1x), MCHP (113.5x), MTSI (118.9x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master LIN's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full LIN research report

Free account — no credit card

LIN

33.5x

Sector Median

23.1x

Sector Avg

33.7x

How LIN's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.